EUVIMEDEUVIMED entdecken
Crossref

The Effects of Human Papillomavirus Status and Treatment on the Positive Predictive Value of Post-radiotherapy 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Advanced Head and Neck Squamous Cell Carcinoma

S Zhou, C Chan, Y C Lau, R Rulach, H Dyab, F Hendry, C Wilson, S Schipani, C Lamb, D Grose, A James, C Maxfield und 2 weitere

Clinical Oncology · 2023-12 · 35 (12) · e699-e707

DOI: 10.1016/j.clon.2023.09.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Oncology, 2023-12. Verfasst von S Zhou und 13 weiteren Autor:innen. Beteiligte Einrichtung: The Beatson West of Scotland Cancer Centre, Glasgow, UK. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Papillomavirus Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Cancer Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: The high negative predictive value of post-chemoradiation (CRT) positron emission tomography-computed tomography (PET-CT) is well established in head and neck squamous cell cancers (HNSCC). The positive predictive value (PPV) remains under scrutiny, with increasing evidence that it is affected by several factors. The aim of this study was to assess the PPV of post-treatment PET-CT for residual nodal disease when stratified by treatment modality and tumour human papillomavirus (HPV) status. MATERIALS AND METHODS: This was a retrospective cohort study in a tertiary oncology centre carried out between January 2013 and December 2019. Patients were radically treated with radiotherapy only/CRT for node-positive HNSCC. PET-CT nodal responses were categorised as complete, equivocal (EQR) or incomplete (ICR), and outcomes extracted from electronic records. RESULTS: In total, 480 patients were evaluated, all had a minimum potential follow-up of 2 years, with a median of 39.2 months. The PPV of 12-week PET-CT was significantly different between HPV-positive (22.5%) and HPV-unrelated (52.7%) disease, P < 0.001. It was also significantly different between the CRT (24.8%) and radiotherapy-only (51.1%) groups, P = 0.001. The PPV of an EQR was significantly less than an ICR, irrespective of HPV status and primary treatment modality. In HPV-positive disease, the PPV of an EQR was 9.0% for the CRT group compared with 21.4% for radiotherapy only, P = 0.278. The PPV in those who achieved an ICR was 34.2% in the CRT group, significantly lower than 70.0% in the radiotherapy-only group, P = 0.03. CONCLUSION: The PPV of 12-week PET-CT is significantly lower for HPV-positive compared with HPV-unrelated HNSCC. It is poorer in patients with HPV-positive disease treated with CRT compared with radiotherapy alone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Head and Neck NeoplasmsPapillomavirus InfectionsHumansSquamous Cell Carcinoma of Head and NeckPositron Emission Tomography Computed TomographyFluorodeoxyglucose F18Predictive Value of TestsHuman Papillomavirus VirusesRetrospective Studies

Stichwörter der Autor:innen

Chemoradiation therapyPET-CT scanhead and neck cancerhuman papillomavirus infectionnegative predictive valuepositive predictive valueradiation therapysquamous cell cancer

Substanzen

Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • The Beatson West of Scotland Cancer Centre, Glasgow, UK.
  • University Hospital Ayr, Ayr, UK.
  • Royal Alexandra Hospital, Glasgow, UK.
  • West of Scotland PET Centre, Gartnavel General Hospital, Glasgow, UK.
  • The Beatson West of Scotland Cancer Centre, Glasgow, UK. Electronic address: Claire.Paterson2@ggc.scot.nhs.uk.

Förderung

  • Cancer Research UK

Zitieren

APA

Zhou, S., Chan, C., Lau, Y. C., Rulach, R., Dyab, H., Hendry, F., Wilson, C., Schipani, S., Lamb, C., Grose, D., James, A., Maxfield, C., Dempsey, M. F., & Paterson, C. (2023). The Effects of Human Papillomavirus Status and Treatment on the Positive Predictive Value of Post-radiotherapy 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Advanced Head and Neck Squamous Cell Carcinoma. Clinical Oncology, 35(12), e699-e707. https://doi.org/10.1016/j.clon.2023.09.006

Vancouver

Zhou S, Chan C, Lau YC, Rulach R, Dyab H, Hendry F, et al. The Effects of Human Papillomavirus Status and Treatment on the Positive Predictive Value of Post-radiotherapy 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Advanced Head and Neck Squamous Cell Carcinoma. Clinical Oncology. 2023;35(12):e699-e707. doi:10.1016/j.clon.2023.09.006

BibTeX
@article{Zhou2023,
  author = {Zhou, S and Chan, C and Lau, Y C and Rulach, R and Dyab, H and Hendry, F and Wilson, C and Schipani, S and Lamb, C and Grose, D and James, A and Maxfield, C and Dempsey, M-F and Paterson, C},
  title = {The Effects of Human Papillomavirus Status and Treatment on the Positive Predictive Value of Post-radiotherapy 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Advanced Head and Neck Squamous Cell Carcinoma},
  journal = {Clinical Oncology},
  year = {2023},
  volume = {35},
  number = {12},
  pages = {e699--e707},
  doi = {10.1016/j.clon.2023.09.006}
}
Kostenlos starten →